Preclinical Promise and Clinical Challenges for Innovative Therapies Targeting Liver Fibrogenesis
Tamer A. Addissouky(University of Babylon), Naglaa Elarabany(Damietta University), Ayman El‐Baz(King Abdullah University of Science and Technology), Ibrahim El Tantawy El Sayed(Menoufia University), Yuliang Wang(Shanghai Jiao Tong University), Majeed M. A. Ali(Alrafidain University College)
Cited by 35
Related Papers
Oxidative stress and inflammation: elucidating mechanisms of smoking-attributable pathology for therapeutic targeting
|Bulletin of the National Research Centre/Bulletin of the National Research Center|2024|90
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
|Egyptian Liver Journal|2024|80
Recent trends in Helicobacter pylori management: harnessing the power of AI and other advanced approaches
|Beni-Suef University Journal of Basic and Applied Sciences|2023|47
MLIF Modulates Microglia Polarization in Ischemic Stroke by Targeting eEF1A1
|Frontiers in Pharmacology|2021|44
Shaping the Future of Cardiac Wellness: Exploring Revolutionary Approaches in Disease Management and Prevention
|Journal of Clinical Cardiology|2024|36